Cannabis Use and Subjective Response to Alcohol in the Human Laboratory

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2022 May 6

PMID 35523112

Authors

Steven J Nieto

Alexandra Venegas

Jazzlyne Hudson

Lara A Ray

Affiliations

Soon will be listed here.

Abstract

Background: Cannabis is often used in combination with alcohol; yet, whether cannabis use impacts risk factors for alcohol use disorder (AUD) remains unknown. Subjective response (SR) to alcohol represents a biobehavioral risk factor for subsequent heavy drinking and for developing AUD. Given the high prevalence of alcohol and cannabis co-use, it is plausible to hypothesize that cannabis users differ in SR to alcohol compared to non-cannabis users. The purpose of this study is to examine the influence of past-month cannabis use on subjective response to alcohol in the human laboratory.

Methods: This study culled data from multiple alcohol administration trials to test whether cannabis users, compared to non-cannabis users, differed in subjective response to alcohol, comprised of four domains: stimulation, sedation, negative affect, and craving. Non-treatment-seeking heavy drinkers (N = 168) completed a battery of self-report scales of mood and alcohol/cigarette/cannabis use and problems. All participants completed an intravenous alcohol administration session wherein SR domains were measured at the following breath alcohol concentrations (BrAC): baseline (i.e., 0), 20, 40, and 60 mg%.

Results: Multilevel statistical analyses revealed that cannabis users had a greater reduction in negative affect during alcohol administration, compared to non-cannabis users. No significant differences were found for the other SR domains.

Conclusions: Using a large sample and advanced data analytic methods, this study extends the literature by suggesting that cannabis users are more sensitive to alcohol-induced reductions in negative affect compared to non-cannabis users. This work extends research on how cannabis use may influence risk factors for AUD, such as subjective response to alcohol.

Citing Articles

Daily diary study of associations between alcohol, cannabis, co-use and sleep quality in individuals with intentions to use cannabis to cope with anxiety.

Sznitman S, Martin-Willett R, Ma W, Karoly H, Bidwell L Drug Alcohol Rev. 2023; 43(2):501-511.

PMID: 37985016 PMC: 10922432. DOI: 10.1111/dar.13778.

Changes over time in endorsement of 11 DSM-IV alcohol use disorder (AUD) criteria in young adults with persistent or recurrent AUD in The Collaborative Study on the Genetics of Alcoholism.

Schuckit M, Smith T, Danko G, Tear J, Hennies J, Mendoza L Alcohol Clin Exp Res (Hoboken). 2023; 47(5):919-929.

PMID: 36924463 PMC: 10308878. DOI: 10.1111/acer.15054.

References

Bujarski S, Jentsch J, Roche D, Ramchandani V, Miotto K, Ray L . Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm. Neuropsychopharmacology. 2018; 43(9):1891-1899. PMC: 6046045. DOI: 10.1038/s41386-018-0086-9. View

Waddell J . Between- and within-group effects of alcohol and cannabis co-use on AUD/CUD in the NSDUH 2002-2019. Drug Alcohol Depend. 2021; 225:108768. DOI: 10.1016/j.drugalcdep.2021.108768. View

Falk D, Yi H, Hiller-Sturmhofel S . An epidemiologic analysis of co-occurring alcohol and drug use and disorders: findings from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). Alcohol Res Health. 2013; 31(2):100-10. PMC: 3860461. View

Ray L, Bujarski S, Roche D . Subjective Response to Alcohol as a Research Domain Criterion. Alcohol Clin Exp Res. 2016; 40(1):6-17. DOI: 10.1111/acer.12927. View

Ray L, Bujarski S, Shoptaw S, Roche D, Heinzerling K, Miotto K . Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. Neuropsychopharmacology. 2017; 42(9):1776-1788. PMC: 5520778. DOI: 10.1038/npp.2017.10. View

Grodin E, Bujarski S, Venegas A, Baskerville W, Nieto S, Jentsch J . Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool. Alcohol Alcohol. 2019; 54(6):574-583. PMC: 7306183. DOI: 10.1093/alcalc/agz075. View

Ballard M, de Wit H . Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers. Pharmacol Biochem Behav. 2010; 97(4):627-31. PMC: 3018238. DOI: 10.1016/j.pbb.2010.11.013. View

Ray L, MacKillop J, Leventhal A, Hutchison K . Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication. Alcohol Clin Exp Res. 2009; 33(12):2154-61. PMC: 3081518. DOI: 10.1111/j.1530-0277.2009.01053.x. View

Sullivan J, Sykora K, Schneiderman J, Naranjo C, Sellers E . Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989; 84(11):1353-7. DOI: 10.1111/j.1360-0443.1989.tb00737.x. View

10.

Bohn M, Krahn D, Staehler B . Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res. 1995; 19(3):600-6. DOI: 10.1111/j.1530-0277.1995.tb01554.x. View

11.

Saunders J, Aasland O, Babor T, De la Fuente J, Grant M . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993; 88(6):791-804. DOI: 10.1111/j.1360-0443.1993.tb02093.x. View

12.

King A, Vena A, Hasin D, deWit H, OConnor S, Cao D . Subjective Responses to Alcohol in the Development and Maintenance of Alcohol Use Disorder. Am J Psychiatry. 2021; 178(6):560-571. PMC: 8222099. DOI: 10.1176/appi.ajp.2020.20030247. View

13.

McCabe S, Arterberry B, Dickinson K, Evans-Polce R, Ford J, Ryan J . Assessment of Changes in Alcohol and Marijuana Abstinence, Co-Use, and Use Disorders Among US Young Adults From 2002 to 2018. JAMA Pediatr. 2020; 175(1):64-72. PMC: 7551219. DOI: 10.1001/jamapediatrics.2020.3352. View

14.

Ronen A, Chassidim H, Gershon P, Parmet Y, Rabinovich A, Bar-Hamburger R . The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks. Accid Anal Prev. 2010; 42(6):1855-65. DOI: 10.1016/j.aap.2010.05.006. View

15.

Ray L, Green R, Roche D, Bujarski S, Hartwell E, Lim A . Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial. Alcohol Clin Exp Res. 2017; 42(3):613-623. PMC: 6086578. DOI: 10.1111/acer.13586. View

16.

Lukas S, Benedikt R, MENDELSON J, Kouri E, Sholar M, Amass L . Marihuana attenuates the rise in plasma ethanol levels in human subjects. Neuropsychopharmacology. 1992; 7(1):77-81. View

17.

Cerda M, Wall M, Keyes K, Galea S, Hasin D . Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend. 2011; 120(1-3):22-7. PMC: 3251168. DOI: 10.1016/j.drugalcdep.2011.06.011. View

18.

Flannery B, Volpicelli J, Pettinati H . Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res. 1999; 23(8):1289-95. View

19.

Martin C, Earleywine M, Musty R, Perrine M, Swift R . Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res. 1993; 17(1):140-6. DOI: 10.1111/j.1530-0277.1993.tb00739.x. View

20.

Erblich J, Earleywine M . Distraction does not impair memory during intoxication: support for the attention-allocation model. J Stud Alcohol. 1995; 56(4):444-8. DOI: 10.15288/jsa.1995.56.444. View